Hepatic Cell News Volume 6.46 | Dec 16 2022

    0
    38








    2022-12-16 | HCN 6.46


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.46 – 16 December, 2022
    TOP STORY

    PRDM1/BLIMP1 Induces Cancer Immune Evasion by Modulating the USP22-SPI1-PD-L1 Axis in Hepatocellular Carcinoma Cells

    Tumoral Prdm1 overexpression upregulated PD-L1 levels, dampening anti-tumor immunity in vivo, and neutralized the anti-tumor efficacy of Prdm1 overexpression in immune-competent mouse models.
    [Nature Communications]

    Full Article

    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Human iPSC-Hepatocyte Modeling of Alpha-1 Antitrypsin Heterozygosity Reveals Metabolic Dysregulation and Cellular Heterogeneity

    Investigators described the derivation of syngeneic induced pluripotent stem cells (iPSCs) engineered to determine the effects of Z alpha-1 antitrypsin heterozygosity in iPSC-hepatocytes.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Mechanistic Target of Rapamycin Complex 1 Orchestrates the Interplay between Hepatocytes and Kupffer Cells to Determine the Outcome of Immune-Mediated Hepatitis

    Scientists dissected the impact of activated mTORC1 on the cell-cell interaction of Kupffer cells (KCs) and hepatocyte in immune-mediated hepatitis. In the liver from patients with AIH and mice administrated with Con-A, mTORC1 was activated in both KCs and hepatocytes.
    [Cell Death & Disease]

    Full Article

    Catalpol Inhibits Hepatic Stellate Cell Activation by Reducing the Formation and Changing the Contents of Hepatocyte-Derived Extracellular Vesicles

    Mouse serum extracellular vesicles were isolated and identified using nanoparticle tracking analysis and transmission electron microscopy. Mouse hepatocytes and primary hepatic stellate cells were used to investigate the cell-to-cell crosstalk.
    [Journal of Cell Communication and Signaling]

    Abstract

    Rhamnetin Ameliorates Non-Alcoholic Steatosis and Hepatocellular Carcinoma In Vitro

    Researchers established reliable in vitro non-alcoholic steatohepatitis models using different mixtures of variable ratios and concentrations of oleic acid and palmitic acid combinations using HepG2 cell lines.
    [Molecular and Cellular Biochemistry]

    Full Article

    Lyve-1 Deficiency Enhances the Hepatic Immune Microenvironment Entailing Altered Susceptibility to Melanoma Liver Metastasis

    Hepatic architecture, liver size, endothelial differentiation, and angiocrine functions were unaltered in Lyve-1-KO. Hyaluronan plasma levels were significantly increased in Lyve-1-KO.
    [Cancer Cell International]

    Full Article

    Melatonin Alleviates Diet-Induced Steatohepatitis by Targeting Multiple Cell Types in the Liver to Suppress Inflammation and Fibrosis

    Scientists evaluated the protection and the mechanisms of action of citrus flavanone metabolites, hesperetin 7-glucuronide and 3-(4′-hydroxyphenyl) propanoic acid, on pancreatic β-cell function under oxidative stress induced by cholesterol using the global proteomics approach.
    [Food & Function]

    Abstract

    Luteolin Ameliorates Palmitate-Induced Lipotoxicity in Hepatocytes by Mediating Endoplasmic Reticulum Stress and Autophagy

    In the presence of palmitic acid, reactive oxygen species production was increased at three hours, followed by enhancement of expression of p-PERK, ATF4, p-eIF2α, CHOP, and TXNIP and p-p62 and LC3II/LC3I ratio, in both primary hepatocytes and AML12 cells.
    [Food and Chemical Toxicology]

    Full Article

    Treating Inflammation to Combat Non-Alcoholic Fatty Liver Disease

    Inflammation is an important driver in the pathogenesis of non-alcoholic steatohepatitis, and the mechanisms underlying inflammation in non-alcoholic fatty liver disease represent possible therapeutic targets.
    [Journal of Endocrinology]

    Full Article
    Stay up-to-date with the latest stem cell research by listening to the Stem Cell Podcast!
    REVIEWS

    Common Mechanisms in Pediatric Acute Liver Failure

    Recovery of the native liver depends on activation of apoptotic and regenerative pathways, including the integrated stress response (ISR; e.g., PERK), p53, and HNF4α.
    [Trends in Molecular Medicine]

    Full Article

    The Spleen Tyrosine Kinase (SYK): A Crucial Therapeutic Target for Diverse Liver Diseases

    The blockage of spleen tyrosine kinase (SYK) activity using small molecule modulators is considered as a significant therapeutic strategy against liver diseases, and both hepatic SYK and non-hepatic SYK could become highly promising therapeutic targets.
    [Heliyon]

    Full Article

    INDUSTRY AND POLICY NEWS

    UK-Based Biotech Submits Patent for Transformational Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)

    Genflow has announced that it has filed a new patent application with the US Patent and Trademark Office that relates to variants of Sirtuin-6, and the gene variant’s therapeutic uses for the treatment of two disorders involving the liver: NAFLD, and non-alcoholic steatohepatitis.
    [Genflow (First Longevity Ltd)]

    Press Release

    Markey Cancer Center Receives American Cancer Society Grant to Continue Faculty Research Program

    The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society to support a long-standing faculty research program.
    [University of Kentucky]

    Press Release

    FEATURED EVENT

    Next Generation Antibody Therapeutics: From Discovery to Patient

    February 19 – 22, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    Faculty Positions – Translational Biomedical Research

    Rutgers Biomedical and Health Sciences – Newark, New Jersey, United States

    Senior Scientist – Liver Team

    Mammoth Biosciences, Inc. – Brisbane, California, United States

    Research Associate – Immunology and Liver Disease

    The Ottawa Hospital Research Institute – Ottawa, Ontario, Canada

    Postdoctoral Scientist – Genomic Informatics

    University of Oxford – Oxford, England, United Kingdom

    Postdoctoral Fellow – Cancer Tumor Microenvironment

    Centre for Oncology and Immunology – Hong Kong, Hong Kong

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter